Etienne D. Foucher
R&D Department
Marseille, 13009, France
Marseille, 13009, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
CLEC-1 promotes early IFN response in cDC1s and favors immune dysregulation during sepsis in mice.
Journal: iScience
Published: February 10, 2026
BTN2A1 targeting reprograms M2-like macrophages and TAMs via SYK and MAPK signaling.
Journal: Cell reports
Published: February 14, 2024
Vγ9Vδ2 T-cells Are Potent Inhibitors of SARS-CoV-2 Replication and Represent Effector Phenotypes in Patients With COVID-19.
Journal: The Journal of infectious diseases
Published: October 18, 2023
BTN3A Targeting Vγ9Vδ2 T Cells Antimicrobial Activity Against Coxiella burnetii-Infected Cells.
Journal: Frontiers in immunology
Published: April 07, 2022
Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus.
Journal: Frontiers in immunology
Published: February 02, 2021
CXCR5 and ICOS expression identifies a CD8 T-cell subset with TFH features in Hodgkin lymphomas.
Journal: Blood advances
Published: February 10, 2018
BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC).
Journal: Oncoimmunology
Published: July 13, 2017
The angiotensin II type 2 receptor activates flow-mediated outward remodelling through T cells-dependent interleukin-17 production.
Journal: Cardiovascular research
Published: December 01, 2015
IL-34- and M-CSF-induced macrophages switch memory T cells into Th17 cells via membrane IL-1α.
Journal: European journal of immunology
Published: February 27, 2014
IL-34 and macrophage colony-stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells.
Journal: Hepatology (Baltimore, Md.)
Published: January 06, 2014
Last Updated: 09/26/2026